Tag Archives: Jason Aryeh

A Director at Ligand Pharma (NASDAQ: LGND) is Buying Shares

Today, a Director at Ligand Pharma (LGND – Research Report), Jason Aryeh, bought shares of LGND for $22.73K. This is Aryeh’s first Buy trade following 14 Sell transactions. In addition to Jason Aryeh, 2 other LGND executives reported Buy trades